| Closed |
SWOG-9326 |
Phase II Trial of Altretamine for Consolidation of Clinical Complete Response in Patients with Stage III Epithelial Ovarian Cancer |
9/1/1993 |
7/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9429 |
Phase II Trial of Carboplatin and VP-16 With Concurrent For Poor-Risk Stage III Non-Small Cell Lung Carcinoma |
8/15/1994 |
9/1/1995 |
100% |
|
Published
|
| Closed |
S9618 |
Phase II Trial of Carboplatin Followed by Dose Intense Paclitaxel, Followed by Maintenance Paclitaxel Therapy in Stage IV Ovarian, Fallopian Tube and Peritoneal Cancers |
10/1/1996 |
9/15/1999 |
96% |
|
Published
|
| Closed |
SWOG-9235 |
Phase II Trial of Casodex in Advanced Prostate Cancer Patients Who Failed Conventional Hormonal Manipulation |
12/15/1993 |
6/1/1994 |
96% |
|
Published
|
| Closed |
S9705 |
Phase II Trial of Cisplatin, Etoposide and Paclitaxel (Taxol®) With G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer |
8/15/1997 |
7/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9518 |
Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas |
4/1/1996 |
10/15/1997 |
55% |
|
Published
|
| Closed |
SWOG-9207 |
Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer |
1/1/1993 |
6/1/1995 |
62% |
|
Published
|
| Closed |
SWOG-9424 |
Phase II Trial of High Dose Tamoxifen Plus Cisplatin Chemotherapy in Metastatic Non-Small Cell Lung Cancer |
11/15/1994 |
12/1/1996 |
75% |
|
Published
|
| Closed |
SWOG-8268 |
Phase II Trial of Human Lymphoblastoid Interferon(Wellferon™) in Metastatic Renal Adenocarcinoma |
9/20/1982 |
4/25/1983 |
|
|
|
| Closed |
S9619 |
Phase II Trial of Intraperitoneal Cisplatin and Intravenous and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian Cancer, Intergroup |
5/15/1996 |
5/15/1998 |
100% |
|
Published
|
| Closed |
SWOG-8729 |
Phase II Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Pancreas |
3/1/1988 |
1/1/1990 |
77% |
|
Published
|
| Closed |
SWOG-9212 |
Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma |
5/15/1994 |
1/15/1997 |
100% |
|
Published
|
| Closed |
S0526 |
Phase II Trial of Pemetrexed in Stage IIIB and IV BAC |
7/1/2006 |
10/1/2008 |
25% |
|
Published
|
| Closed |
SWOG-8930 |
Phase II Trial of Piroxantrone for Advanced or Metastatic Soft-Tissue Sarcomas |
6/15/1990 |
12/1/1991 |
83% |
|
Published
|
| Closed |
SWOG-8918 |
Phase II Trial of Piroxantrone in Endometrial Cancer |
7/1/1991 |
5/1/1994 |
55% |
|
Published
|
| Closed |
S0506 |
Phase II Trial of PS-341 (Bortezomib, NSC-681239) Followed by the Addition of Gemcitabine at Progression in Recurrent or Metastatic Nasopharyngeal Carcinoma |
8/15/2006 |
1/10/2007 |
0% |
|
|
| Closed |
SWOG-9324 |
Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer |
3/15/1995 |
7/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-8904 |
Phase II Trials of Merbarone and Piroxantrone in Ovarian Cancer |
12/1/1990 |
2/15/1993 |
63% |
|
Published
|
| Closed |
S0417 |
Phase II VTD in Refractory Multiple Myeloma |
8/1/2005 |
6/15/2007 |
8% |
|
|
| Closed |
SWOG-7841 |
Phase II-III Comparison of FAM vs DHAD in the Treatment of Advanced Gastric Adenocarcinoma |
2/16/1979 |
8/25/1982 |
|
|
|
